These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 15096079)

  • 21. A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania.
    McElroy SL; Keck PE; Stanton SP; Tugrul KC; Bennett JA; Strakowski SM
    J Clin Psychiatry; 1996 Apr; 57(4):142-6. PubMed ID: 8601548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia.
    Suh GH; Greenspan AJ; Choi SK
    Int J Geriatr Psychiatry; 2006 Jul; 21(7):654-60. PubMed ID: 16821257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The utility of intramuscular ziprasidone in the management of acute psychotic agitation.
    Mendelowitz AJ
    Ann Clin Psychiatry; 2004; 16(3):145-54. PubMed ID: 15517847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atypical antipsychotic medications in the psychiatric emergency service.
    Currier GW
    J Clin Psychiatry; 2000; 61 Suppl 14():21-6. PubMed ID: 11154013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral risperidone plus oral lorazepam versus standard care with intramuscular conventional neuroleptics in the initial phase of treating individuals with acute psychosis.
    Lejeune J; Larmo I; Chrzanowski W; Witte R; Karavatos A; Schreiner A; Lex A; Medori R
    Int Clin Psychopharmacol; 2004 Sep; 19(5):259-69. PubMed ID: 15289699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjunctive treatment of manic agitation with lorazepam versus haloperidol: a double-blind study.
    Lenox RH; Newhouse PA; Creelman WL; Whitaker TM
    J Clin Psychiatry; 1992 Feb; 53(2):47-52. PubMed ID: 1541605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized, double-blind comparison of risperidone versus low-dose risperidone plus low-dose haloperidol in treating schizophrenia.
    Lin CH; Kuo CC; Chou LS; Chen YH; Chen CC; Huang KH; Lane HY
    J Clin Psychopharmacol; 2010 Oct; 30(5):518-25. PubMed ID: 20814315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic reviews of assessment measures and pharmacologic treatments for agitation.
    Zeller SL; Rhoades RW
    Clin Ther; 2010 Mar; 32(3):403-25. PubMed ID: 20399981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol.
    Smulevich AB; Khanna S; Eerdekens M; Karcher K; Kramer M; Grossman F
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):75-84. PubMed ID: 15572276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of benzodiazepines to control disruptive behavior in inpatients.
    Salzman C
    J Clin Psychiatry; 1988 Dec; 49 Suppl():13-5. PubMed ID: 3058683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study.
    Battaglia J; Moss S; Rush J; Kang J; Mendoza R; Leedom L; Dubin W; McGlynn C; Goodman L
    Am J Emerg Med; 1997 Jul; 15(4):335-40. PubMed ID: 9217519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An open, randomized, comparative study of efficacy and safety of risperidone and haloperidol in schizophrenia.
    Tamrakar SM; Nepal MK; Koirala NR; Sharma VD; Gurung CK; Adhikari SR
    Kathmandu Univ Med J (KUMJ); 2006; 4(2):152-60. PubMed ID: 18603890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol.
    Andrezina R; Josiassen RC; Marcus RN; Oren DA; Manos G; Stock E; Carson WH; Iwamoto T
    Psychopharmacology (Berl); 2006 Oct; 188(3):281-92. PubMed ID: 16953381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective, open study of long-acting injected risperidone versus oral antipsychotics in 88 chronically psychotic patients.
    Girardi P; Serafini G; Pompili M; Innamorati M; Tatarelli R; Baldessarini RJ
    Pharmacopsychiatry; 2010 Mar; 43(2):66-72. PubMed ID: 20099224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An open-label, randomized, controlled trial of zotepine and risperidone for acutely ill, hospitalized, schizophrenic patients with symptoms of agitation.
    Chan HY; Lin AS; Chen KP; Cheng JS; Chen YY; Tsai CJ
    J Clin Psychopharmacol; 2013 Dec; 33(6):747-52. PubMed ID: 24100785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of long-acting risperidone in stable patients with schizoaffective disorder.
    Lasser R; Bossie CA; Gharabawi G; Eerdekens M; Nasrallah HA
    J Affect Disord; 2004 Dec; 83(2-3):263-75. PubMed ID: 15555724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective, randomized, controlled trial of benzodiazepines and nitroglycerine or nitroglycerine alone in the treatment of cocaine-associated acute coronary syndromes.
    Honderick T; Williams D; Seaberg D; Wears R
    Am J Emerg Med; 2003 Jan; 21(1):39-42. PubMed ID: 12563578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of risperidone on nursing burden associated with caring for patients with dementia.
    Frank L; Kleinman L; Ciesla G; Rupnow MF; Brodaty H
    J Am Geriatr Soc; 2004 Sep; 52(9):1449-55. PubMed ID: 15341545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral risperidone, olanzapine and quetiapine versus haloperidol in psychotic agitation.
    Villari V; Rocca P; Fonzo V; Montemagni C; Pandullo P; Bogetto F
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):405-13. PubMed ID: 17900775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative efficacy and safety of long-acting risperidone and risperidone oral tablets.
    Chue P; Eerdekens M; Augustyns I; Lachaux B; Molcan P; Eriksson L; Pretorius H; David AS
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):111-7. PubMed ID: 15572280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.